Method of preparing controls for glycated hemoglobin S-A1c derived from healthy blood cells
US8546144B2 · kind B2 · utility
5Cited by
14References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 17, 2011 |
| Grant date | Oct 1, 2013 |
| Priority date | — |
| Expiry date | Nov 17, 2031 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T436/104998
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
By way of summary, the present invention meets some or all of the above needs by providing in a first aspect a method comprising contacting red blood cells in a suspension medium containing mannose under conditions such that the concentration of S-Alc glycated hemoglobin is increased to greater than about 6 percent by weight of the hemoglobin in the red blood cells. Preferably the suspension medium is an aqueous suspension medium. In preferred embodiments, the method is performed at about ambient temperature, 18° C. to about 23° C.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.